← Back
Data updated: Mar 10, 2026
KENTON
Pharmaceuticals
KENTON is a generic drug manufacturer with 5 FDA-approved products.
1998
Since
5
Drugs
-
Trials
19
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ANASTROZOLE 2025-10-24
Labeling
ANASTROZOLE 2025-10-24
Labeling
ANASTROZOLE 2025-10-24
Labeling
SELEGILINE HYDROCHLORIDE 2025-09-04
Labeling
ANASTROZOLE 2025-07-15
Labeling
ANASTROZOLE 2025-07-15
Labeling
ANASTROZOLE 2025-07-08
Labeling
ANASTROZOLE 2025-07-08
Labeling
REPAGLINIDE 2025-07-01
Labeling
REPAGLINIDE 2025-07-01
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (3)
Company Info
- First Approval
- 1998-04-30
- Latest
- 2023-10-17
- Applications
- 5